Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Rajtar

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Biochemical Pharmacology|February 1, 1985
Prostaglandins and human platelet aggregation. Implications for the anti-aggregating activity of thromboxane-synthase inhibitorsG Rajtar, C Cerletti, M N Castagnoli, et al.
Farmaco (Societa Chimica Italiana : 1989)|December 4, 1998
2-Substituted-3-oxoisothiazolo[5,4-b]pyridines as potential central nervous system and antimycobacterial agentsW Malinka, S Ryng, M Sieklucka-Dziuba, et al.
Farmaco (Societa Chimica Italiana : 1989)|April 29, 1998
Transformation of some pyrido[2,3-d]pyrimidine derivatives into other di- and triheterocyclic systemsH Sladowska, M Bodetko, M Sieklucka-Dziuba, et al.
Farmaco (Societa Chimica Italiana : 1989)|June 1, 1996
Synthesis and pharmacological evaluation of N-aryl(pyrimidinyl) piperazinylalkyl (hydroxyalkyl) derivatives of 1,2,3,4-tetra- and 1,2,3,4,5,6-hexahydropyrido[3,4-d]pyridazinesH Sladowska, J Potoczek, G Rajtar, et al.
Acta Poloniae Pharmaceutica|November 1, 1996
Investigations on the synthesis and properties of some N-[4-phenyl(2-pyrimidinyl)-1-piperazinyl]alkyl (hydroxyalkyl)-3,4-pyridinedicarboximidesH Sladowska, J Potoczek, G Rajtar, et al.
Die Pharmazie|February 23, 2000
Synthesis of some N-substituted 3,4-pyrroledicarboximides as potential CNS depressive agentsW Malinka, M Sieklucka-Dziuba, G Rajtar, et al.
Farmaco (Societa Chimica Italiana : 1989)|January 1, 1995
Investigations on the synthesis and properties of some N-arylpiperazinylalkyl derivatives of 1,4-dioxo (1,4,5-trioxo)-1,2,3,4-tetra (and 1,2,3,4,5,6-hexa)hydropyrido[3,4-d]pyridazinesH Sladowska, J Potoczek, M Sieklucka-Dziuba, et al.
Archivum Immunologiae Et Therapiae Experimentalis|January 1, 1986
Pharmacological evaluation of ifosfamide and its enantiomers in laboratory animalsZ Kleinrok, B Chmielewska, J S Czuczwar, et al.
Archivum Immunologiae Et Therapiae Experimentalis|January 1, 1986
Comparison of subacute toxicity of rubidomycine and its four derivativesZ Kleinrok, G Rajtar, B Chmielewska, et al.
Archivum Immunologiae Et Therapiae Experimentalis|January 1, 1986
comparison of pharmacological properties of cyclophosphamide and its enantiomersZ Kleinrok, B Chmielewska, J S Czuczwar, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Biochemical Pharmacology|February 1, 1985
Prostaglandins and human platelet aggregation. Implications for the anti-aggregating activity of thromboxane-synthase inhibitorsG Rajtar, C Cerletti, M N Castagnoli, et al.
Farmaco (Societa Chimica Italiana : 1989)|December 4, 1998
2-Substituted-3-oxoisothiazolo[5,4-b]pyridines as potential central nervous system and antimycobacterial agentsW Malinka, S Ryng, M Sieklucka-Dziuba, et al.
Farmaco (Societa Chimica Italiana : 1989)|April 29, 1998
Transformation of some pyrido[2,3-d]pyrimidine derivatives into other di- and triheterocyclic systemsH Sladowska, M Bodetko, M Sieklucka-Dziuba, et al.
Farmaco (Societa Chimica Italiana : 1989)|June 1, 1996
Synthesis and pharmacological evaluation of N-aryl(pyrimidinyl) piperazinylalkyl (hydroxyalkyl) derivatives of 1,2,3,4-tetra- and 1,2,3,4,5,6-hexahydropyrido[3,4-d]pyridazinesH Sladowska, J Potoczek, G Rajtar, et al.
Acta Poloniae Pharmaceutica|November 1, 1996
Investigations on the synthesis and properties of some N-[4-phenyl(2-pyrimidinyl)-1-piperazinyl]alkyl (hydroxyalkyl)-3,4-pyridinedicarboximidesH Sladowska, J Potoczek, G Rajtar, et al.
Die Pharmazie|February 23, 2000
Synthesis of some N-substituted 3,4-pyrroledicarboximides as potential CNS depressive agentsW Malinka, M Sieklucka-Dziuba, G Rajtar, et al.
Farmaco (Societa Chimica Italiana : 1989)|January 1, 1995
Investigations on the synthesis and properties of some N-arylpiperazinylalkyl derivatives of 1,4-dioxo (1,4,5-trioxo)-1,2,3,4-tetra (and 1,2,3,4,5,6-hexa)hydropyrido[3,4-d]pyridazinesH Sladowska, J Potoczek, M Sieklucka-Dziuba, et al.
Archivum Immunologiae Et Therapiae Experimentalis|January 1, 1986
Pharmacological evaluation of ifosfamide and its enantiomers in laboratory animalsZ Kleinrok, B Chmielewska, J S Czuczwar, et al.
Archivum Immunologiae Et Therapiae Experimentalis|January 1, 1986
Comparison of subacute toxicity of rubidomycine and its four derivativesZ Kleinrok, G Rajtar, B Chmielewska, et al.
Archivum Immunologiae Et Therapiae Experimentalis|January 1, 1986
comparison of pharmacological properties of cyclophosphamide and its enantiomersZ Kleinrok, B Chmielewska, J S Czuczwar, et al.
Pageof 5